Growth Metrics

Incyte (INCY) Change in Accured Expenses (2016 - 2025)

Incyte (INCY) has disclosed Change in Accured Expenses for 16 consecutive years, with $138.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 6.76% year-over-year to $138.5 million, compared with a TTM value of -$148.2 million through Dec 2025, down 153.13%, and an annual FY2025 reading of -$148.2 million, down 153.13% over the prior year.
  • Change in Accured Expenses was $138.5 million for Q4 2025 at Incyte, up from $115.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $138.5 million in Q4 2025 and bottomed at -$476.7 million in Q2 2025.
  • Average Change in Accured Expenses over 5 years is $35.6 million, with a median of $62.8 million recorded in 2022.
  • The sharpest move saw Change in Accured Expenses soared 2430.46% in 2022, then tumbled 510.9% in 2025.
  • Year by year, Change in Accured Expenses stood at $46.4 million in 2021, then increased by 3.04% to $47.8 million in 2022, then soared by 143.08% to $116.2 million in 2023, then rose by 11.66% to $129.8 million in 2024, then increased by 6.76% to $138.5 million in 2025.
  • Business Quant data shows Change in Accured Expenses for INCY at $138.5 million in Q4 2025, $115.1 million in Q3 2025, and -$476.7 million in Q2 2025.